Phase 2 biotech developing novel immunotherapies for cancer.
Industry: Health Care
Latest Trade: $0.45 0.00 (0.0%)
First Day Return: -21.3%
Return from IPO: -94.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 05/26/2021 |
Offer Price | $8.00 |
Price Range $8.00 - $10.00 | |
Offer Shares (mm) | 7.0 |
Deal Size ($mm) | $56 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/19/2021 |
Offer Price | $8.00 |
Price Range $8.00 - $10.00 | |
Offer Shares (mm) | 7.0 |
Deal Size ($mm) | $56 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
EF Hutton |
Revere Securities |
Company Data | |
---|---|
Headquarters | Miramar, FL, United States |
Founded | 2018 |
Employees at IPO | 40 |
Website www.hcwbiologics.com |